UNITED STATES 
                   SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549
                               __________

                                FORM 8-K
                             CURRENT REPORT

 Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported): January 18, 2005


                       PETMED EXPRESS, INC.
        -----------------------------------------------------
        (Exact name of registrant as specified in its charter) 

                 Commission file number 000-28827
                                        ---------

          FLORIDA                           65-0680967
   ---------------------------             ------------
  (State or other jurisdiction            (IRS Employer
of incorporation or organization)	Identification No.)
	
	
1441 S.W. 29th Avenue, Pompano Beach, Florida    33069
---------------------------------------------   ---------
  (Address of principal executive offices)      (Zip Code)

Registrant's telephone number, including area code: (954) 979-5995
                                                    --------------

                          Not Applicable
    ----------------------------------------------------------
   (Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

[  ] Written communications pursuant to Rule 425 under the Securities Act

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act





Item 7.01   Regulation FD Disclosure
---------   ------------------------

On January 18, 2005, PetMed Express, Inc. issued a press release stating
that it will announce its December 31, 2004 quarter end financial results
and host a conference call to review the results on Monday, January 24, 2005.
A copy of this news release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.

The information furnished in this Item 9, intended to be furnished under
Item 12, is instead furnished under Item 9 in accordance with SEC Release
33-8216.  This information shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act") nor shall such information be incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such filing.

Item 9.01   Financial Statements and Exhibits
---------   ---------------------------------

(c)	Exhibits

99.1	Press Release issued by PetMed Express, Inc. on January 18, 2005





                             SIGNATURES


	Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.

                                  
PETMED EXPRESS, INC.
(The "Registrant")

Date: January 18, 2005

By: /s/  Menderes Akdag
    ---------------------
         Menderes Akdag

      	Chief Executive Officer 
      	(principal executive officer)

By: /s/  Bruce S. Rosenbloom
    -------------------------
         Bruce S. Rosenbloom

         Chief Financial Officer
         (principal financial and accounting officer)





                           EXHIBIT INDEX

Exhibit No.   Description


99.1          Press Release issued by PetMed Express on January 18, 2005